Pharmaceutical company Galderma hosted press and specialist guests at The Bulgari Hotel for an exclusive educational event highlighting its bio-stimulator, Sculptra.
The afternoon featured a panel discussion considering the use of bio-stimulator Sculptra and its correlation with consumer trends such as weight loss drugs. The talk was opened by Wojciech Konczalik, Galderma’s medical affairs lead, who provided an overview of Galderma.
Plastic surgeon Mr Ash Soni shared his in-clinic experience with Sculptra. Cosmetic dermatologist Dr. Sabrina Fabi also joined virtually, sharing findings from a study she participated in last year, which revealed a novel, fat-mediated regenerative mechanism of action unique to Sculptra.
During a Q&A, Aesthetics asked the panel why biostimulators are increasing in popularity. Mr Soni explained, “People don’t want a quick fix anymore. They’re focusing on the long term, what they will look like in five, 10 or 15 years time, and discussing skin health, skin quality and collagen, indicating that shift in medial aesthetics.”
On the event, Konczalik commented, “We had an esteemed group of both journalists, influencers and everybody interested in the aesthetics space. And what is more exciting in the aesthetics space than bio-regeneration? This is the future of medical aesthetics, making sure you are reversing the signs of ageing and bringing your patients back to the beginning.”
